Physician profile
Rajiv K Sethi
NPI 1720090608
$2,932,165.14
in general payments reported to CMS, 2019-2025
24 companies · $375K in 2025
The $375K reported for 2025 was more than what 98% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182K · 2020: $1.1M · 2021: $236K · 2022: $335K · 2023: $312K · 2024: $393K · 2025: $375K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $839K · Royalty Or License: $142K · Travel and Lodging: $53K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $15K · Grant: $5,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $839,465.99 |
| Royalty Or License | $142,275.39 |
| Travel and Lodging | $52,664.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,630.54 |
| Food and Beverage | $14,779.29 |
| Grant | $5,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,058,801.92 | 2019-2020 | |
| Orthofix Medical, INC. | $428,452.68 | 2019-2025 | Firebird Nxg, Mariner, 7d Surgical System |
| Viseon, INC. | $427,871.88 | 2021-2025 | Maxview System - Lateral Set |
| Stryker Corporation | $405,406.87 | 2019-2025 | Mako, Cayman Plate System, Niagara Lateral Access System |
| Alphatec Spine, INC | $178,819.22 | 2021-2025 | Other - Miscellaneous, Invictus Open, Safeop |
| Nuvasive, INC. | $116,519.14 | 2019-2023 | Reline, Pulse, Tlif |
| Medicrea USA, Corp. | $62,332.30 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $57,366.37 | 2021-2022 | |
| Medtronic, INC. | $49,260.80 | 2021-2025 | Unid_pass, Mazor X System |
| Globus Medical, INC. | $42,779.66 | 2020-2025 | Reline, Excelsius Gps, Reflect/Reflect Hde |
| Augmedics INC. | $42,144.62 | 2023-2025 | Xvision |
| Axis Spine Technologies INC. | $26,906.25 | 2022 | |
| Mighty Oak Medical | $19,202.96 | 2020-2025 | |
| Highridge Medical LLC | $8,478.68 | 2024-2025 | Spine-None, Prolift Expandable Interbody, 12mm X 28mm, Large 15 Degree |
| Medical Device Business Services, INC. | $5,337.94 | 2022-2024 | Viper, Expedium Verse, Teligen |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $961.54 | 2021-2023 | |
| Depuy Synthes Sales INC. | $353.34 | 2019-2021 | |
| Biedermann Motech, INC. | $316.60 | 2023 | Moss Vrs Spinal System |
| Icotec Medical INC. | $260.85 | 2022-2023 | Icotec Blackarmor Spine System |
| Mml US, INC. | $250.68 | 2022 | |
| Providence Medical Technology, INC. | $223.89 | 2025 | |
| Centinel Spine, LLC | $78.95 | 2025 | Prodisc C Vivo |
| Woven Orthopedic Technologies, LLC | $38.00 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$374,755.64 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.